Potential to Be the First Targeted Fast-Acting Therapy for GBS, Setting a New Standard of Care BLA Submission with U.S./European Data from ...

Agenus Inc. , a leader in immuno-oncology innovation, today announced that France's National Agency for Medicines and Health Products Safety (ANSM) has approved an updated national treatment protocol ...

Announces receipt of FDA letter stating it has identified deficiencies that preclude labeling discussions for Anaphylm at this time Receives ...

Hello New York! I want to thank the Pride of The Orange marching band. The best marching band in the country as far as I’m ...

As Secretary of State, the President’s onetime foe now offers him lavish displays of public praise—and will execute his ...

Pürblack, a science-driven wellness company recognized for providing the highest-quality shilajit and advanced peptide formulations, is calling on the wellness industry to raise the bar on ...

Precigen transitioned to a commercial stage company with the US approval of PAPZIMEOS in August 2025, the first-and-only FDA-approved treatment for adults with RRP ...

Eisai And Nuvation Bio Enter Into Exclusive Licensing Agreement For Taletrectinib In Europe And Additional Countries Outside The U.S., China And Japan. Eisai and Nuvation Bio Enter into Exclusive ...

Announces receipt of FDA letter stating it has identified deficiencies that preclude labeling discussions for Anaphylm at this time Receives confirmation from FDA that Agency's review of Anaphylm NDA ...

Canada is wrestling with how gene-editing should translate to voluntary genetically modified food labels, or whether it even ...

MINNEAPOLIS, MN, UNITED STATES, January 11, 2026 /EINPresswire.com/ -- Itiliti Health is proud to announce that South ...